Online citations, reference lists, and bibliographies.
← Back to Search

Pancreatic Ductal Adenocarcinoma: A Radiomics Nomogram Outperforms Clinical Model And TNM Staging For Survival Estimation After Curative Resection

Tiansong Xie, X. Wang, M. Li, T. Tong, Xiaoli Yu, Z. Zhou
Published 2020 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Objectives To identify a CT-based radiomics nomogram for survival prediction in patients with resected pancreatic ductal adenocarcinoma (PDAC). Methods A total of 220 patients (training cohort n  = 147; validation cohort n  = 73) with PDAC were enrolled. A total of 300 radiomics features were extracted from CT images. And the least absolute shrinkage and selection operator algorithm were applied to select features and develop a radiomics score (Rad-score). The radiomics nomogram was constructed by multivariate regression analysis. Nomogram discrimination, calibration, and clinical usefulness were evaluated. The association of the Rad-score and recurrence pattern in PDAC was evaluated. Results The Rad-score was significantly associated with PDAC patient’s disease-free survival (DFS) and overall survival (OS) (both p  < 0.001 in two cohorts). Incorporating the Rad-score into the radiomics nomogram resulted in better performance of the survival prediction than that of the clinical model and TNM staging system. In addition, the radiomics nomogram exhibited good discrimination, calibration, and clinical usefulness in both the training and validation cohorts. There was no association between the Rad-score and recurrence pattern. Conclusions The radiomics nomogram integrating the Rad-score and clinical data provided better prognostic prediction in resected PDAC patients, which may hold great potential for guiding personalized care for these patients. The Rad-score was not a predictor of the recurrence pattern in resected PDAC patients. Key Points • The Rad-score developed by CT radiomics features was significantly associated with PDAC patients’ prognosis. • The radiomics nomogram integrating the Rad-score and clinical data has value to permit non-invasive, low-cost, and personalized evaluation of prognosis in PDAC patients. • The radiomics nomogram outperformed clinical model and the TNM staging system in terms of survival estimation.
This paper references
10.1158/1078-0432.CCR-17-3783
Radiomics Signature on Magnetic Resonance Imaging: Association with Disease-Free Survival in Patients with Invasive Breast Cancer
Hyunjin Park (2018)
10.1016/j.ebiom.2018.09.007
Radiomics signature of computed tomography imaging for prediction of survival and chemotherapeutic benefits in gastric cancer
Y. Jiang (2018)
10.3390/cancers11040497
Head and Body/Tail Pancreatic Carcinomas Are Not the Same Tumors
D. Birnbaum (2019)
10.1016/S0140-6736(16)32409-6
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
J. Neoptolemos (2017)
10.1371/journal.pone.0207362
Feasibility of CT radiomics to predict treatment response of individual liver metastases in esophagogastric cancer patients
R. Klaassen (2018)
10.1007/s00259-017-3837-7
Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery
M. Kirienko (2017)
10.1245/s10434-019-07471-z
Proton Radiotherapy for Isolated Local Recurrence of Primary Resected Pancreatic Ductal Adenocarcinoma
PhD Takuya Mizumoto MD (2019)
10.1186/s12880-017-0209-5
CT texture features are associated with overall survival in pancreatic ductal adenocarcinoma – a quantitative analysis
A. Eilaghi (2017)
10.1038/nrclinonc.2017.141
Radiomics: the bridge between medical imaging and personalized medicine
P. Lambin (2017)
10.1016/j.ejrad.2017.02.033
Resectable pancreatic adenocarcinoma: Role of CT quantitative imaging biomarkers for predicting pathology and patient outcomes.
C. Cassinotto (2017)
10.1245/s10434-017-6323-3
Survival Prediction in Pancreatic Ductal Adenocarcinoma by Quantitative Computed Tomography Image Analysis
Marc A. Attiyeh (2017)
10.1038/s41598-017-08310-5
Limits of radiomic-based entropy as a surrogate of tumor heterogeneity: ROI-area, acquisition protocol and tissue site exert substantial influence
L. Dercle (2017)
10.1158/1078-0432.CCR-18-1305
A Combined Nomogram Model to Preoperatively Predict Histologic Grade in Pancreatic Neuroendocrine Tumors
W. Liang (2018)
10.1038/s41598-018-25627-x
Tumor heterogeneity of pancreas head cancer assessed by CT texture analysis: association with survival outcomes after curative resection
Gabin Yun (2018)
10.1001/jama.2013.279201
Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial.
H. Oettle (2013)
Radiomics signature onmagnetic resonance imaging: association with disease-free survival in patients with invasive breast cancer
ParkH (2018)
10.1002/mp.13159
CT radiomics to predict high‐risk intraductal papillary mucinous neoplasms of the pancreas
J. Chakraborty (2018)
10.1245/s10434-012-2762-z
Re-resection for Isolated Local Recurrence of Pancreatic Cancer is Feasible, Safe, and Associated with Encouraging Survival
O. Strobel (2012)
10.1111/J.2517-6161.1996.TB02080.X
Regression Shrinkage and Selection via the Lasso
R. Tibshirani (1996)
Computer-aided diagnosis of pancreas serous cystic neoplasms: a radiomics method on preopera t ive MDCT images
R Wei (2019)
10.3322/caac.21492
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
F. Bray (2018)
10.1016/j.pan.2019.02.012
Over-expression of low-density lipoprotein receptor-related Protein-1 is associated with poor prognosis and invasion in pancreatic ductal adenocarcinoma.
A. Gheysarzadeh (2019)
10.1007/s00330-018-5574-0
CT prediction of resectability and prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant treatment using image findings and texture analysis
B. Kim (2018)
10.1038/s41598-018-37748-4
Association Between Radiomics Signature and Disease-Free Survival in Conventional Papillary Thyroid Carcinoma
V. Park (2018)
10.1007/s13244-012-0196-6
Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?
Fergus Davnall (2012)
10.1007/s00330-018-5662-1
CT texture analysis of pancreatic cancer
K. Sandrasegaran (2018)
10.1097/SLA.0000000000002234
Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma
V. Groot (2018)
10.1177/1533033818824339
Computer-Aided Diagnosis of Pancreas Serous Cystic Neoplasms: A Radiomics Method on Preoperative MDCT Images
Ran Wei (2019)
10.1007/s00330-019-06142-7
A radiomics approach to predict lymph node metastasis and clinical outcome of intrahepatic cholangiocarcinoma
Gu-Wei Ji (2019)
10.1016/j.jhep.2019.02.023
Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma.
X. Xu (2019)
10.1002/bjs.11295
Meta‐analysis of recurrence pattern after resection for pancreatic cancer
M. Tanaka (2019)
Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
10.1038/s41598-019-41728-7
Prognostic Value of CT Radiomic Features in Resectable Pancreatic Ductal Adenocarcinoma
F. Khalvati (2019)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar